Alpha-Klotho

There are 88 papers on alpha-Klotho in aging research: 1 trial and 68 observational studies in people, 10 in animals, 7 reviews. The newest story, Oct 29, 2026: “Removing an enzyme eased kidney aging and bone loss in mice”.

Biomarker

88 papers study it10 more mention it111 findings

2 new papers in 30 daysSee all 98 papers on alpha-Klotho

At a glance

Higher alpha-Klotho is linked with lower biological age, less frailty, and lower risk of combined cognitive-physical decline in human observational studies, and with lower mortality in people with diabetes. Human studies also link it with higher insulin resistance. Senescent cell clearance increases alpha-Klotho in mice; a human trial reports increased urinary alpha-Klotho after dasatinib plus quercetin in people with idiopathic pulmonary fibrosis.

111 findings in 58 papers from 2016 to 2026, 7 of them since April 2026

“we observed an independent and significant negative correlation between α-Klotho and ACR (β = -12.22; 95% CI, -23.91, -0.53, p = 0.0448)”
Association between Serum Soluble α-Klotho and Urinary Albumin Excretion in Middle-Aged and Older US Adults: NHANES 2007-2016Journal of clinical medicine2023doi:10.3390/jcm12020637
  • Human trial1
  • Humans68
  • Animals10
  • In silico1

Interventions

19

Cigarette smoking

downin humans2no changein humans1

2 studies
  1. Cigarette smoking is linked with lower alpha-Klotho in humans (current smoking, adults aged 40-79 years) (reductions of 10.81%, 6.43% and 3.38% for light, moderate and heavy smoking versus non-smoking).

    Humanscurrent smoking, adults aged 40-79 yearsn = 4,196

  2. Cigarette smoking was not clearly linked with alpha-Klotho in the 60-79 age group.

    Humansin the 60-79 age group

  3. Cigarette smoking is linked with lower alpha-Klotho in humans after full adjustment, total study population (β = -34.89; 95% CI -54.97 to -14.81; P = 0.0013).

    Humansafter full adjustment, total study populationn = 11,559

More on Cigarette smoking

Dasatinib + quercetin

upin humans1upin mice1

2 studies
  1. Dasatinib + quercetin increases alpha-Klotho in humans (idiopathic pulmonary fibrosis).

    Human trialidiopathic pulmonary fibrosisurine

  2. Dasatinib + quercetin increases alpha-Klotho in mice (streptozotocin-induced diabetes).

    Animalsstreptozotocin-induced diabeteskidney5 and 50 mg/kg, respectively5-daymales

More on Dasatinib + quercetin

Smoking cessation

upin humans1no changein humans1

2 studies
  1. Smoking cessation is linked with higher alpha-Klotho in humans (former smokers, after full multivariable adjustment) (+1.20 pg/mL per year of abstinence).

    Humansformer smokers, after full multivariable adjustment

  2. Smoking cessation was not clearly linked with alpha-Klotho in humans (total study population) (P = 0.1148).

    Humanstotal study populationn = 11,559

More on Smoking cessation

Iron

downin humans1upin humans1

1 study
  1. Iron is linked with lower alpha-Klotho in humans (above the turning point of 1.863 mg/100 kcal) (β -0.018; P = 0.035).

    Humansabove the turning point of 1.863 mg/100 kcalabove 1.863 mg/100 kcal

  2. Iron is linked with higher alpha-Klotho in humans (below the turning point of 1.863 mg/100 kcal) (β 0.045; P = 0.011).

    Humansbelow the turning point of 1.863 mg/100 kcalbelow 1.863 mg/100 kcal

More on Iron

Alcohol

no changein humans1downin humans1

1 study
  1. Alcohol was not clearly linked with alpha-Klotho in people with cardiovascular disease, chronic kidney disease, or cancer.

    Humansin people with cardiovascular disease, chronic kidney disease, or cancer

  2. Alcohol is linked with lower alpha-Klotho in humans after full adjustment; moderate intake versus never drinking (β = -62.64 (95% CI -88.86, -36.43), P < 0.001).

    Humansafter full adjustment; moderate intake versus never drinkingmoderate intaken = 11,558

More on Alcohol

Micronutrient intake

no changein humans1

1 study
  1. Micronutrient intake was not clearly linked with alpha-Klotho in humans (overall population, multivariable linear regression) (all P > 0.05).

    Humansoverall population, multivariable linear regression

More on Micronutrient intake

Coffee

no changein humans1

1 study
  1. Coffee was not clearly linked with alpha-Klotho in humans.

    Humansdecaffeinatedn = 9,811

More on Coffee

Hexavalent chromium

upin humans1

1 study
  1. Hexavalent chromium is linked with higher alpha-Klotho in humans (per 2.7-fold increase in blood Cr) (+11.45% (6.13 to 17.04) per 2.7-fold increase in blood Cr).

    Humansper 2.7-fold increase in blood Crn = 304

More on Hexavalent chromium

Molybdenum

upin humans1

1 study
  1. Molybdenum is linked with higher alpha-Klotho in humans after adjustment for potential confounders.

    Humansafter adjustment for potential confoundersn = 4,071

More on Molybdenum

Barium

upin humans1

1 study
  1. Barium is linked with higher alpha-Klotho in humans after adjustment for potential confounders.

    Humansafter adjustment for potential confoundersn = 4,071

More on Barium

All 19

Effects

10

HOMA-IR

no changein humans2

2 studies
  1. Alpha-Klotho was not clearly linked with HOMA-IR in humans among participants with BMI below 25.0 or at least 30 kg/m2 (P for interaction = 0.18).

    Humansamong participants with BMI below 25.0 or at least 30 kg/m2

  2. Alpha-Klotho was not clearly linked with HOMA-IR in humans among participants with BMI <25.0 or ≥30 kg/m2 (non-overweight strata).

    Humansamong participants with BMI <25.0 or ≥30 kg/m2 (non-overweight strata)

More on HOMA-IR

Estimated glomerular filtration rate

mediatesin humans2

2 studies
  1. Alpha-Klotho is linked with estimated glomerular filtration rate in humans (association between blood lead and eGFR) (12.76% of the lead–eGFR relationship).

    Humansassociation between blood lead and eGFRkidneyn = 11,032

  2. Alpha-Klotho is linked with estimated glomerular filtration rate in humans (mediating the association of diet quality (HEI-2015) with eGFR) (5.6-10.5% of the association mediated).

    Humansmediating the association of diet quality (HEI-2015) with eGFRkidneyn = 12,817

More on Estimated glomerular filtration rate

Incident diabetes

no changein humans1

1 study
  1. Alpha-Klotho was not clearly linked with incident diabetes in humans (overall and in each BMI subgroup).

    Humansoverall and in each BMI subgroupfollow-up of 3 years

More on Incident diabetes

CSF Aβ42/p-tau181

upin humans1

1 study
  1. Alpha-Klotho is linked with higher CSF Aβ42/p-tau181 in humans (men only; sex-stratified association).

    Humansmen only; sex-stratified associationcsfmales

More on CSF Aβ42/p-tau181

Plasma P-TAU217 and NfL

downin humans1

1 study
  1. Alpha-Klotho is linked with lower plasma P-TAU217 and NfL in humans (men only; sex-stratified association).

    Humansmen only; sex-stratified associationplasmamales

More on Plasma P-TAU217 and NfL

Dual cognitive-physical decline

no changein humans1

1 study
  1. Alpha-Klotho was not clearly linked with dual cognitive-physical decline in humans (overall sample and BMI strata; trajectory-based decline).

    Humansoverall sample and BMI strata; trajectory-based declineup to 15 years of follow-upn = 461

Diabetes mellitus

no changein humans1

1 study
  1. Alpha-Klotho was not clearly linked with diabetes mellitus in humans (odds ratio 1.34 (95% CI 0.35-5.10)).

    Humansamong overweight participants (BMI 25.0-29.9 kg/m2); odds 1.34 times higher, not significantn = 394

More on Diabetes mellitus

Biological age

mediatesin humans1

1 study
  1. Alpha-Klotho is linked with biological age in humans (mediating the association of DII with biological age) (10.13% of the DII–biological age association (P < 0.001)).

    Humansmediating the association of DII with biological agen = 3,054

More on Biological age

Frailty

no changein humans1

1 study
  1. Alpha-Klotho was not clearly linked with frailty in humans (frail versus non-frail geriatric patients) (0.76 ± 1.01 ng/ml vs 0.54 ± 0.61 ng/ml, p = 0.286).

    Humansfrail versus non-frail geriatric patientsn = 89

Interstitial lung abnormalities

no changein humans1

1 study
  1. Alpha-Klotho was not clearly linked with interstitial lung abnormalities in humans (comparison of ILA subjects with healthy controls).

    Humanscomparison of ILA subjects with healthy controls

More on Interstitial lung abnormalities

Upstream

4

Oxidative stress and ROS signaling

mediatesin humans1

1 study
  1. Oxidative stress and ROS signaling is linked with alpha-Klotho in humans (partial mediation of the remnant cholesterol–α-Klotho association, via SOD) (58.18% mediated).

    Humanspartial mediation of the remnant cholesterol–α-Klotho association, via SODn = 1,052

More on Oxidative stress and ROS signaling

Atherogenic index of plasma

no changein humans1

1 study
  1. Atherogenic index of plasma was not clearly linked with alpha-Klotho in humans after adjustment for risk factors, weighted multivariate linear regression.

    Humansafter adjustment for risk factors, weighted multivariate linear regressionmales

More on Atherogenic index of plasma

Inflammatory biomarkers

mediatesin humans1

1 study
  1. Inflammatory biomarkers are linked with alpha-Klotho in humans (mediating the association of polypharmacy with α-klotho) (proportion mediated 6.11% to 11.82%).

    Humansmediating the association of polypharmacy with α-klothon = 3,569

More on Inflammatory biomarkers

Senescent cell clearance

upin mice1

1 study
  1. senescent cell clearance increases alpha-Klotho in mice.

    Animalsincreased senescent cell burden, including naturally-aged, diet-induced obese, or senescent cell-transplanted miceurine, kidney, and brain

Associations

64

Atherogenic index of plasma

downin humans2

2 studies
  1. Atherogenic index of plasma is associated with alpha-Klotho in humans after age adjustment (rho -0.289).

    Humansafter age adjustmentn = 86

  2. Atherogenic index of plasma is associated with alpha-Klotho in humans after adjustment for risk factors, weighted multivariate linear regression.

    Humansafter adjustment for risk factors, weighted multivariate linear regressionfemales

More on Atherogenic index of plasma

HOMA-IR

upin humans2

2 studies
  1. Alpha-Klotho is associated with HOMA-IR in humans among overweight participants (BMI 25.0–29.9 kg/m2) (0.51 higher HOMA-IR per log unit (95% CI 0.07–0.94)).

    Humansamong overweight participants (BMI 25.0–29.9 kg/m2)assessed 3 years after enrollmentn = 370

  2. Alpha-Klotho is associated with HOMA-IR in humans among overweight participants (BMI 25.0-29.9 kg/m2), after adjustment for covariates (0.42 units higher HOMA-IR per log higher alpha-klotho (95% CI 0.09-0.75)).

    Humansamong overweight participants (BMI 25.0-29.9 kg/m2), after adjustment for covariatesn = 394

More on HOMA-IR

Cognitive impairment

upin humans1upin reviews1

2 studies
  1. Alpha-Klotho is associated with cognitive impairment in humans (maintenance hemodialysis patients, cross-sectional).

    Humansmaintenance hemodialysis patients, cross-sectional

  2. Alpha-Klotho is associated with cognitive impairment (reduced alpha-klotho expression).

    Reviewreduced alpha-klotho expression

More on Cognitive impairment

Mortality

downin humans2HR 0.61

2 studies
  1. Alpha-Klotho is linked with a lower risk of mortality in humans (diabetes) (HR 0.61 (0.36, 0.96; p = 0.043)).

    Humansdiabetes

  2. Alpha-Klotho is associated with mortality in humans (Higher versus lower serum α-klotho concentrations).

    HumansHigher versus lower serum α-klotho concentrationsserum5 years

Cognitive function

upin humans2

2 studies
  1. Alpha-Klotho is associated with cognitive function in humans (subgroup analysis) (p = 0.005, 95% CI -3.18 to -0.57).

    Humanssubgroup analysis

  2. Alpha-Klotho is associated with cognitive function in humans.

    Humans

Frailty

mixedin humans1downin humans1OR 0.63

1 study
  1. Alpha-Klotho is associated with frailty in humans (non-linear association shown by restricted cubic spline (p<0.001)) (turning point 785.7 pg/ml (ln 6.67)).

    Humansnon-linear association shown by restricted cubic spline (p<0.001)n = 7,052

  2. Alpha-Klotho is linked with a lower risk of frailty in humans (weighted logistic regression after adjustment for covariables; ln-transformed) (OR 0.63 (95% CI 0.50, 0.79)).

    Humansweighted logistic regression after adjustment for covariables; ln-transformedn = 7,052

Coronary atherosclerosis

upin humans1

1 study
  1. Alpha-Klotho predicts coronary atherosclerosis in humans (presence defined as Agatston score > 0) (AUC 0.754 (95% CI 0.654-0.855)).

    Humanspresence defined as Agatston score > 0coronary arteryn = 86

More on Coronary atherosclerosis

CAD-RADS severity

downin humans1OR 0.525

1 study
  1. Alpha-Klotho is associated with CAD-RADS severity in humans after adjustment for age, sex, BMI, and AIP (OR 0.525).

    Humansafter adjustment for age, sex, BMI, and AIPcoronary arteryn = 86

More on CAD-RADS severity

Agatston score

downin humans1

1 study
  1. Alpha-Klotho is associated with Agatston score in humans (rho -0.540 (Agatston score), rho -0.549 (CAD-RADS)).

    Humanscoronary arteryn = 86

More on Agatston score

Bone mineral density

upin humans1

1 study
  1. Alpha-Klotho is associated with bone mineral density in humans.

    Humansbone

All 64

Funding

9 grants since 2016

Japan Society for the Promotion of Science¥41.1MNational Institute of Diabetes and Digestive and Kidney Diseases$782KAgence Nationale de la Recherche€348K

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    In one human study, serum alpha-Klotho is inversely associated with CAD-RADS and Agatston scores and predicts coronary atherosclerosis.

  2. Summary written from the findings.

Latest

Dec 2025: 5Jan 2026: 5Feb 2026: 2Mar 2026: 3Apr 2026: 1May 2026: 0Jun 2026: 4Jul 2026: 0Aug 2026: 5Sep 2026: 1Oct 2026: 0Nov 2026: 127 papers in 12 months
Aging Cell

Removing an enzyme eased kidney aging and bone loss in mice

Deleting the enzyme’s gene in kidney filtering cells reduced kidney damage and age-related bone loss in aged mice; a drug also improved kidney and bone measures.Deleting the enzyme’s gene in kidney filtering cells reduced kidney damage and age-related bone loss in aged mice; a drug also improved kidney and bone measures.

Mouse studyBones and joints

See all 98 papers on alpha-Klotho